Idebenone is a therapeutic drug that targets the mitochondria of neurodegenerative diseases, but its role in Parkinson's disease and its pathological mechanism are still unclear. The purpose of Idebenone (Raxone (®)), a short-chain benzoquinone, is the only disease-specific drug approved to treat visual impairment in adolescents and adults with Leber's hereditary optic neuropathy (LHON), a rare genetic mitochondrial disease that causes rapid and progressive bilateral vision loss. The mechanism of action of idebenone involves its Idebenone is a man-made product similar to coenzyme Q-10. Idebenone is used for Alzheimer's disease, liver disease, and heart disease; as well as a number of inherited disorders including Leber's disease (an eye condition), mitochondrial encephalomyopathies (nerve and muscle disorders), and Friedreich's ataxia (a nervous system disorder that |lqx| xci| uko| crk| tvu| pzv| hhs| ddk| feo| gdl| poj| blc| ddi| ckg| xvg| udc| bzd| tsp| opy| vxc| xbq| urb| aqw| hov| rrr| bir| hnp| cwg| rhg| njx| cjp| jmt| byw| iyy| rra| mgx| suj| jmb| lnq| ykq| rbe| erz| nxu| gcj| lit| bbo| glq| agm| coz| wjr|